1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Investigación quirúrgica en urología y trasplante renal

Investigación quirúrgica en urología y trasplante renal

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Andras I, Telecan T, Piana A, Boissier R, Hevia V, Prudhomme T, Amparore D, Bertolo R, Carbonara U, Erdem S, Diana P, Ingels A, Kara O, Marandino L, Marchioni M, Muselaers S, Pavan N, Pecoraro A, Roussel E, Crisan N, Territo A, Campi R.

    How to manage renal masses in kidney transplant recipients? A collaborative review by the EAU-YAU kidney transplantation and renal cancer working groups.

    Actas Urologicas Espanolas . : .

    [doi:10.1016/j.acuroe.2023.04.006]

  • Mata Alcaraz M, Mínguez Ojeda C, Artiles Medina A, Duque Ruiz G, Hevia Palacios M, Arias Fúnez F, Burgos Revilla FJ.

    Extracorporeal shock wave lithotripsy for lower calyx stones: predicting treatment success.

    Actas Urologicas Espanolas . : .

    [doi:10.1016/j.acuroe.2023.07.004]

  • Schwartzmann I, García Barreras S, D'Anna M, Parejo V, Torneo Ruiz I, Tagalos Muñoz AC, Bravo-Balado A, Diana P, Peri L, Domínguez Esteban M, Fernández Guzmán E.

    Water vapor thermal therapy: Technical variations among spanish hospitals and efficacy at 2-year follow-up.

    Actas Urologicas Espanolas . : .

    [doi:10.1016/j.acuroe.2023.07.001]

  • Guerrero P, Albarrán V, González-Merino C, García de Quevedo C, Sotoca P, Chamorro J, Rosero DI, Barrill A, Alía V, Calvo JC, Moreno J, Pérez de Aguado P, Álvarez-Ballesteros P, San Román M, Serrano JJ, Soria A, Olmedo ME, Saavedra C, Cortés A, Gómez A, Lage Y, Ruiz Á, Ferreiro MR, Longo F, Guerra E, Martínez-Delfrade Í, Garrido P, Gajate P.

    Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

    ONCOLOGIST . : .

    [doi:10.1093/oncolo/oyae284]

  • Rivero Belenchón I, Congregado Ruíz CB, Gómez Ciriza G, Gómez Dos Santos V, Burgos Revilla FJ, Medina López RA.

    Reply by Authors.

    JOURNAL OF UROLOGY . : .

    [doi:10.1097/JU.0000000000004462]

  • Rivero Belenchón I, Congregado Ruíz CB, Gómez Ciriza G, Gómez Dos Santos V, Burgos Revilla FJ, Medina López RA.

    Reply by Authors.

    JOURNAL OF UROLOGY . : .

    [doi:10.1097/JU.0000000000004469]

  • Gallioli A, Uleri A, Verri P, Tedde A, Mertens LS, Moschini M, Del Giudice F, Soria F, Laukhtina E, Subiela JD, Krajewski W, D'Andrea D, Mari A, Marcq G, Mori K, Teoh J, Afferi L, Albisinni S, Sanguedolce F, Palou J, Breda A, Pradere B.

    Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working Group.

    European Urology Focus . : .

    [doi:10.1016/j.euf.2025.01.009]

  • Longoni M, Scilipoti P, Soria F, Pradere B, Krajewski W, D'Andrea D, Mari A, Del Giudice F, Pichler R, Subiela JD, Afferi L, Albisinni S, Gallioli A, Mertens LS, Laukhtina E, Mori K, Radziszewski P, Slusarczyk A, Shariat SF, Necchi A, Xylinas E, Gontero P, Rouprêt M, Montorsi F, Briganti A, Moschini M.

    Oncological Outcomes in Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future Perspectives.

    European Urology Oncology . : .

    [doi:10.1016/j.euo.2025.03.007]

  • Scilipoti P, Longoni M, de Angelis M, Zaurito P, Slusarczyk A, Soria F, Pradere B, Krajewski W, D'Andrea D, Mari A, Giudice FD, Pichler R, Subiela JD, Marcq G, Gallioli A, Afferi L, Mastroianni R, Simone G, Albisinni S, Mertens LS, Laukhtina E, Oberneder K, Rodríguez Elena JL, Aranda J, Puentedura AL, Velasco JC, Contieri R, Hurle R, Mori K, Radziszewski P, Shariat SF, Gontero P, Necchi A, Rouprêt M, Montorsi F, Salonia A, Briganti A, Moschini M.

    Long-term Oncological Outcomes for Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (BCG): A Comparative Analysis of Adequate Versus Inadequate BCG Treatment.

    European Urology Focus . : .

    [doi:10.1016/j.euf.2025.04.033]

  • Pichler R, van Creij NCH, Mertens LS, Del Giudice F, Koll F, Soria F, Subiela JD, Plage H, Tymoszuk P, Mayr R, Klinglmair G, Seeber A, Pichler M, Günther M, Ormanns S, Compérat E, Li R, Moschini M, Pradére B.

    FGFR1/3 Signaling as an Achilles' Heel of Phenotypic Diversity in Urothelial Carcinoma.

    European Urology Oncology . : .

    [doi:10.1016/j.euo.2025.07.005]

  • Subiela JD, de la Parra I, Taborda J, Medina AA, Pichler R, Krajewski W, Ojeda CM, Mardomingo AF, Durán PDO, Pérez EL, González-Padilla DA, Aumatell J, Mori K, Scilipoti P, Longoni M, de Angelis M, Caño-Velasco J, Puentedura AL, Pujol LP, Contieri R, Gallioli A, Tukiendorf A, D'Andrea D, Teoh JY, Afferi L, Del Giudice F, Marcq G, Albisinni S, Soria F, Mertens LS, Laukhtina E, Tully K, Mari A, Guerrero-Ramos F, Alvarez-Maestro M, Martín CC, Melendres FA, Buisan O, López-González JA, Dominguez-Escrig JL, Aranda J, Elena JLR, Basile G, Santos VGD, Moschini M, Pradere B, Acosta EA, Palacio FL, Puig AC, Gajate P, Saiz A, Gontero P, Revilla FJB.

    Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapy.

    BJU INTERNATIONAL . : .

    [doi:10.1111/bju.16913]

  • Massari F, Mollica V, Kopp RM, Grande E, Fiala O, Kanesvaran R, Li H, Schieber TJ, Juan Fita MJ, Poprach A, Lolli C, Bourlon MT, de Liaño AG, Grillone F, Sunela K, Rizzo A, Ghosn M, Cerbone L, Taha T, Ürün Y, Molina-Cerrillo J, Alonso-Gordoa T, Lenci E, Martin IO, Abu-Sini H, Rescigno P, Bhuva D, Fay AP, Conteduca V, Yildirim A, Rosellini M, Akova U, Tassinari E, Bölek H, Soares A, Marques Monteiro FS, Buti S, Bilen MA, Santoni M.

    Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study.

    European Urology Focus . : .

    [doi:10.1016/j.euf.2025.05.020]

  • Fernandes C, Viegas V, Artiles Medina A, Martins Silva C, San José L, López-Fando Lavalle L.

    Male pudendal nerve release assisted by laparoscopy and intraoperative neurophysiologic monitoring.

    Neurocirugia (english Edition) . : 500714-500714.

    [doi:10.1016/j.neucie.2025.500714]

  • Fernández O, Molina A, Anido-Herranz U, Alvarez C, Gironés R, Gajate P, Domínguez RG, Ros S, Puente J, Blasco S, Oré-Arce M, Martinez EN, Fernández-Freire A, Del Pozo N, Cassinello J, Lázaro-Quintela M, Arranz F, Crespo G, Abad MT, Llorente M, Sánchez-Hernández A, Juan MJ.

    Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD study.

    CLINICAL & TRANSLATIONAL ONCOLOGY . : .

    [doi:10.1007/s12094-025-03978-y]

  • Capdevila J, Hernando J, Molina-Cerrillo J, Benavent Viñuales M, Garcia-Carbonero R, Teulé A, Custodio A, Jimenez-Fonseca P, Lopez C, Hierro C, Carmona-Bayonas A, Alonso V, Llanos M, Sevilla I, Garcia-Alvarez A, Alonso-Gordoa T, Gallego Jiménez I, Antón-Pascual B, Modrego Sánchez A, Grande E.

    Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A multi-cohort, Basket, Phase II Trial (CABATEN/GETNE-T1914).

    CLINICAL CANCER RESEARCH . : .

    [doi:10.1158/1078-0432.CCR-25-2143]

  • Molina-Cerrillo J, Catto J, Kamat AM, Necchi A, Roupre T M, Grande E.

    Revisiting Neoadjuvant Chemotherapy in Cisplatin-eligible Muscle-invasive Bladder Cancer.

    European Urology Oncology . : .

    [doi:10.1016/j.euo.2025.09.006]

  • Ocanto A, Ciérvide R, Hevia-Palacios V, García R, Gómez V, Cruz P, Olavarría A, Couñago F, López-Campos F.

    Ablative techniques in renal tumours for inoperable patients: Step forward in SBRT.

    Actas Urologicas Espanolas . : 501857-501857.

    [doi:10.1016/j.acuroe.2025.501857]

  • Powles T, Hussain SA, Climent MA, Carbonero IG, Molina-Cerrillo J, Puente J, Borrega P, Malik J, Dourthe LM, Jones R, Castellano D, Durán I, Loriot Y, Priyadarshini G, Szabados B, Jamal F, Wang YQ, Kotriwala N, Jackson-Spence F, Ackerman C, Grande E.

    Three versus six cycles of platinum-based chemotherapy followed by avelumab maintenance as first-line treatment for advanced urothelial cancer: the phase II DISCUS trial.

    Annals of oncology : official journal of the European Society for Medical Oncology . : .

    [doi:10.1016/j.annonc.2025.10.011]